David Cheng

5.1k total citations · 1 hit paper
73 papers, 4.0k citations indexed

About

David Cheng is a scholar working on Physiology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, David Cheng has authored 73 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Physiology, 15 papers in Cellular and Molecular Neuroscience and 13 papers in Molecular Biology. Recurrent topics in David Cheng's work include Alzheimer's disease research and treatments (15 papers), Neuroscience and Neuropharmacology Research (8 papers) and Neuroinflammation and Neurodegeneration Mechanisms (7 papers). David Cheng is often cited by papers focused on Alzheimer's disease research and treatments (15 papers), Neuroscience and Neuropharmacology Research (8 papers) and Neuroinflammation and Neurodegeneration Mechanisms (7 papers). David Cheng collaborates with scholars based in United States, Australia and Qatar. David Cheng's co-authors include Frank M. LaFerla, Masashi Kitazawa, Tim Karl, Brett Garner, David H. Cribbs, Rodrigo Medeiros, Vitaly Vasilevko, Jac Kee Low, Maya A. Koike and Roland Stocker and has published in prestigious journals such as Journal of Neuroscience, Blood and The Journal of Immunology.

In The Last Decade

David Cheng

71 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical Relevance of Biomarkers of Oxidative Stress

2015 648 citations Jeroen Frijhoff, Paul G. Winyard et al. Antioxidants and Redox Signaling profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Cheng United States	34	1.4k	968	758	648	647	73	4.0k
Francesca Bosetti United States	39	1.2k 0.8×	1.5k 1.5×	1.4k 1.8×	728 1.1×	725 1.1×	68	4.9k
Zhiyou Cai China	38	1.8k 1.3×	1.6k 1.6×	1.2k 1.6×	751 1.2×	715 1.1×	105	5.2k
Yan Wu China	40	963 0.7×	1.9k 2.0×	1.1k 1.5×	662 1.0×	1.2k 1.9×	170	5.5k
Wei Qiao Qiu United States	36	2.9k 2.0×	1.9k 1.9×	749 1.0×	664 1.0×	635 1.0×	114	5.8k
Ángel Cedazo-Mı́nguez Sweden	44	2.3k 1.6×	2.3k 2.4×	706 0.9×	595 0.9×	822 1.3×	110	5.4k
Masaki Mogi Japan	43	997 0.7×	1.9k 2.0×	631 0.8×	486 0.8×	457 0.7×	179	5.4k
Chaur‐Jong Hu Taiwan	38	1.5k 1.0×	1.4k 1.4×	825 1.1×	409 0.6×	421 0.7×	242	5.9k
Yang Liu China	40	1.6k 1.1×	1.6k 1.7×	1.6k 2.2×	311 0.5×	357 0.6×	255	5.7k
Ming Tong United States	39	1.4k 1.0×	1.6k 1.7×	545 0.7×	268 0.4×	395 0.6×	113	4.3k
Alice Y. Chang Taiwan	37	1.2k 0.9×	1.7k 1.7×	364 0.5×	330 0.5×	625 1.0×	165	4.7k

Countries citing papers authored by David Cheng

Since Specialization

Citations

This map shows the geographic impact of David Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Cheng more than expected).

Fields of papers citing papers by David Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Cheng. The network helps show where David Cheng may publish in the future.

Co-authorship network of co-authors of David Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of David Cheng. A scholar is included among the top collaborators of David Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Cheng. David Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheng, David, et al.. (2023). ID: 219777 Neuromodulation in a 10-Year-Old With Chronic Abdominal Pain: A Case Report. Neuromodulation Technology at the Neural Interface. 26(4). S48–S48.

Chesworth, Rose, et al.. (2022). Effect of long-term cannabidiol on learning and anxiety in a female Alzheimer’s disease mouse model. Frontiers in Pharmacology. 13. 931384–931384. 18 indexed citations

Trevathan, James K., Jennifer Anders, Evan N. Nicolai, et al.. (2020). Calcium imaging in freely moving mice during electrical stimulation of deep brain structures. Journal of Neural Engineering. 18(2). 26008–26008. 18 indexed citations

Pellegrini, Fabio, Massimiliano Copetti, Francesca Bovis, et al.. (2019). A proof-of-concept application of a novel scoring approach for personalized medicine in multiple sclerosis. Multiple Sclerosis Journal. 26(9). 1064–1073. 14 indexed citations

Frijhoff, Jeroen, Paul G. Winyard, Neven Žarković, et al.. (2015). Clinical Relevance of Biomarkers of Oxidative Stress. Antioxidants and Redox Signaling. 23(14). 1144–1170. 648 indexed citations breakdown →

Chen, Ming-Kai & David Cheng. (2014). What is the role of dosimetry in patients with advanced thyroid cancer?. Current Opinion in Oncology. 27(1). 33–37. 6 indexed citations

Marzese, Diego M., Meilin Liu, Hajime Hirose, et al.. (2014). Brain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosome. Pigment Cell & Melanoma Research. 28(1). 82–93. 46 indexed citations

Cheng, David, Adena S. Spiro, Andrew M. Jenner, Brett Garner, & Tim Karl. (2014). Long-Term Cannabidiol Treatment Prevents the Development of Social Recognition Memory Deficits in Alzheimer's Disease Transgenic Mice. Journal of Alzheimer s Disease. 42(4). 1383–1396. 142 indexed citations

Kim, Woojin S., Hongyun Li, Kalani Ruberu, et al.. (2013). Deletion ofAbca7Increases Cerebral Amyloid-β Accumulation in the J20 Mouse Model of Alzheimer's Disease. Journal of Neuroscience. 33(10). 4387–4394. 155 indexed citations

10.

Rodríguez‐Ortiz, Carlos J., David Cheng, Mathew Blurton‐Jones, et al.. (2013). Neuronal-Specific Overexpression of a Mutant Valosin-Containing Protein Associated with IBMPFD Promotes Aberrant Ubiquitin and TDP-43 Accumulation and Cognitive Dysfunction in Transgenic Mice. American Journal Of Pathology. 183(2). 504–515. 26 indexed citations

11.

Cheng, David, Warren Logge, Jac Kee Low, Brett Garner, & Tim Karl. (2013). Novel behavioural characteristics of the APPSwe/PS1ΔE9 transgenic mouse model of Alzheimer's disease. Behavioural Brain Research. 245. 120–127. 52 indexed citations

12.

Karl, Tim, David Cheng, Brett Garner, & Jonathon C. Arnold. (2012). The therapeutic potential of the endocannabinoid system for Alzheimer's disease. Expert Opinion on Therapeutic Targets. 16(4). 407–420. 35 indexed citations

13.

Logge, Warren, David Cheng, Rose Chesworth, et al.. (2012). Role of Abca7 in Mouse Behaviours Relevant to Neurodegenerative Diseases. PLoS ONE. 7(9). e45959–e45959. 39 indexed citations

14.

Brenner, Barry E., David Cheng, Sunday Clark, & Carlos A. Camargo. (2011). Positive Association between Altitude and Suicide in 2584 U.S. Counties. High Altitude Medicine & Biology. 12(1). 31–35. 97 indexed citations

15.

Karl, Tim, Surabhi Bhatia, David Cheng, Woojin S. Kim, & Brett Garner. (2011). Cognitive phenotyping of amyloid precursor protein transgenic J20 mice. Behavioural Brain Research. 228(2). 392–397. 39 indexed citations

16.

Sun, Shawn X., Maryna Marynchenko, Ritesh Banerjee, et al.. (2011). Cost-effectiveness analysis of roflumilast/tiotropium therapy versus tiotropium monotherapy for treating severe-to-very severe COPD. Journal of Medical Economics. 14(6). 805–815. 10 indexed citations

17.

Kitazawa, Masashi, David Cheng, & Frank M. LaFerla. (2009). Chronic copper exposure exacerbates both amyloid and tau pathology and selectively dysregulates cdk5 in a mouse model of AD. Journal of Neurochemistry. 108(6). 1550–1560. 129 indexed citations

18.

Cheng, David. (2002). The EKG of hypothermia. Journal of Emergency Medicine. 22(1). 87–91. 11 indexed citations

19.

Brenner, Barry E., et al.. (1997). Determinants of reluctance to perform CPR among residents and applicants: The impact of experience on helping behavior. Resuscitation. 35(3). 203–211. 42 indexed citations

20.

Cheng, David, Debra S. Heller, & Changyul Oh. (1991). Endometriosis of the perineum; report of two new cases and a review of literature. European Journal of Obstetrics & Gynecology and Reproductive Biology. 42(1). 81–84. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact